Dina U Gafurbaeva
Overview
Explore the profile of Dina U Gafurbaeva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
10
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rakhmatullina A, Zolotykh M, Filina Y, Valiullina A, Zmievskaya E, Gafurbaeva D, et al.
Cells
. 2024 Nov;
13(22).
PMID: 39594640
CAR-T therapy has revolutionized the field of oncology, offering a promising treatment option for cancer patients. However, the significant morbidity associated with therapy-related toxicity presents a major challenge to its...
2.
Rakhmatullina A, Zolotykh M, Filina Y, Mingaleeva R, Sagdeeva A, Boulygina E, et al.
Transl Oncol
. 2024 Mar;
44:101930.
PMID: 38520912
Tumor employs non-cancerous cells to gain beneficial features that promote growth and survival of cancer cells. Despite intensive research in the area of tumor microenvironment, there is still a lack...
3.
Rakhmatullina A, Mingaleeva R, Gafurbaeva D, Glazunova O, Sagdeeva A, Bulatov E, et al.
J Pers Med
. 2023 Nov;
13(11).
PMID: 38003936
Mesenchymal stem cells (MSCs) are pivotal players in tissue repair and hold great promise as cell therapeutic agents for regenerative medicine. Additionally, they play a significant role in the development...
4.
Gening S, Abakumova T, Gafurbaeva D, Rizvanov A, Antoneeva I, Miftakhova R, et al.
Life (Basel)
. 2021 Aug;
11(8).
PMID: 34440558
Stem properties allow circulating tumor cells (CTCs) to survive in the bloodstream and initiate cancer progression. We aimed to assess the numbers of stem-like CTCs in patients with ovarian cancer...